Edition:
United States

Oncopeptides AB (ONCO.ST)

ONCO.ST on Stockholm Stock Exchange

88.00SEK
15 Dec 2017
Change (% chg)

-0.50kr (-0.56%)
Prev Close
88.50kr
Open
88.50kr
Day's High
89.50kr
Day's Low
86.00kr
Volume
44,778
Avg. Vol
43,766
52-wk High
96.00kr
52-wk Low
41.10kr

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Alan Hulme

66 2010 Chairman of the Board

Jakob Lindberg

45 2011 Chief Executive Officer

Birgitta Stahl

46 2016 Chief Financial Officer

Eva Nordstrom

47 2012 Vice President, Head of Clinical Development

Paula Boultbee

59 2016 Chief Commercial Officer